Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
---|---|
Information provided by: | National Heart, Lung, and Blood Institute (NHLBI) |
ClinicalTrials.gov Identifier: | NCT00000577 |
This study will establish a network of interactive asthma clinical research groups to evaluate current therapies, new therapies, and management strategies for adult asthma.
Condition | Intervention | Phase |
---|---|---|
Asthma Lung Diseases |
Drug: Albuterol Drug: Colchicine Drug: Adrenal Cortex Hormones Drug: Adrenergic-Beta Agonists |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment |
Official Title: | Asthma Clinical Research Network (ACRN) |
Study Start Date: | September 1993 |
Estimated Study Completion Date: | July 2008 |
Ages Eligible for Study: | 18 Years to 75 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Patients with asthma; specific eligibility criteria vary for each study.
United States, California | |
University of California, San Francisco | |
San Francisco, California, United States, 94143 | |
University of California at San Diego | |
La Jolla, California, United States, 92103 | |
United States, Colorado | |
National Jewish Medical & Research Center | |
Denver, Colorado, United States, 80206 | |
United States, Massachusetts | |
Brigham and Women's Hospital | |
Boston, Massachusetts, United States, 02115 | |
United States, Missouri | |
Washington University | |
St. Louis, Missouri, United States, 63110 | |
United States, North Carolina | |
Wake Forest University Health Sciences | |
Winston-Salem, North Carolina, United States, 27103 | |
United States, Wisconsin | |
University of Wisconsin at Madison | |
Madison, Wisconsin, United States, 53792 |
Study Chair: | Homer A. Boushey | University of California, San Francisco |
Study Chair: | William Calhoun | University of Pittsburgh at Pittsburgh |
Study Chair: | Mario Castro | Washington University School of Medicine |
Study Chair: | Vernon Chinchilli | Pennsylvania State University Hershey Medical Center |
Study Chair: | Elliot Israel | Brigham and Women's Hospital |
Study Chair: | Robert F. Lemanske, Jr. | University of Wisconsin at Madison |
Study Chair: | Richard J. Martin | National Jewish Medical & Research Center |
Study Chair: | Stephen P. Peters | Wake Forest University |
Study Chair: | Stephen I. Wasserman | University of California, San Diego |
Study ID Numbers: | 215, U10 HL51823, U10 HL51831, U10 HL51834, U10 HL51843, U10 HL51845, U10 HL56443, U10 HL74073, U10 HL74204, U10 HL74206, U10 HL74208, U10 HL74212, U10 HL74218, U10 HL74225, U10 HL74227, U10 HL74231, Y02 HL51810 |
Study First Received: | October 27, 1999 |
Last Updated: | August 24, 2006 |
ClinicalTrials.gov Identifier: | NCT00000577 |
Health Authority: | United States: Federal Government |
Hypersensitivity Lung Diseases, Obstructive Respiratory Tract Diseases Lung Diseases Albuterol |
Hypersensitivity, Immediate Asthma Colchicine Epinephrine Respiratory Hypersensitivity |
Molecular Mechanisms of Pharmacological Action Immune System Diseases Bronchial Diseases Antineoplastic Agents Therapeutic Uses Mitosis Modulators |
Tubulin Modulators Antimitotic Agents Antirheumatic Agents Gout Suppressants Pharmacologic Actions |